drugset / Trial / NCT00448903

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

NCT00448903

Phase 3 Completed 329 enrolled Rovi Pharmaceuticals Laboratories
RandomizedParallel-groupTriple-blindTreatment

Summary

Chronic foot ulcers are a common, severe and expensive complication in patients with diabetes and often causes lower-extremity amputation. The aim of this study is to evaluate the effect of bemiparin as treatment of diabetic foot ulcers.

Timeline

Start
2007-03
Primary completion
2009-12
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bemiparin Other / unclassified

Indications